Physician
Lelchuk, Boris
Lelchuk, Boris was paid $3.82M by Medicaid between Jan 2018 and Dec 2024, across 73 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoLELCHUK, BORIS
WHEELING, IL 60090
WHEELING, IL 60090
33aNPI1932132123assigned 07/09/2006
33bProvider typePediatrics Physician
28Total paid$3.82M
24GClaims141,965
24DCodes billed73
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#14 of 1,805
Median peer was paid$55K
This provider vs. median69×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,090 | $478K | |
| 2019 | 20,424 | $566K | |
| 2020 | 18,436 | $448K | |
| 2021 | 21,338 | $548K | |
| 2022 | 22,438 | $604K | |
| 2023 | 22,321 | $580K | |
| 2024incomplete | 20,918 | $597K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 31,842 | 24,448 | $1.56M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.2% | 3,594 | 2,905 | $274K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 3,341 | 2,961 | $252K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.2% | 2,855 | 2,493 | $237K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.8% | 2,686 | 2,346 | $185K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.9% | 1,330 | 1,239 | $111K |
| 92551 | 2.7% | 6,914 | 6,212 | $105K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.5% | 298 | 177 | $97K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 5,837 | 5,341 | $91K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 2,820 | 2,631 | $88K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 1,788 | 1,676 | $63K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 3,641 | 3,092 | $58K |
61 more codes
| 90670 | 1.1% | 1,973 | $44K | |
| 92567 | 1.1% | 2,881 | $43K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.0% | 3,263 | $40K |
| 83655 | 1.0% | 3,259 | $39K | |
| 96127 | 1.0% | 2,619 | $38K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,439 | $37K |
| 99173 | <1% | 4,974 | $37K | |
| 90651 | <1% | 817 | $36K | |
| 90686 | <1% | 2,783 | $31K | |
| 87081 | <1% | 4,059 | $24K | |
| 85018 | <1% | 9,312 | $22K | |
| 90633 | <1% | 1,690 | $21K | |
| 36416 | <1% | 4,829 | $20K | |
| 90677 | <1% | 498 | $19K | |
| 81003 | <1% | 7,970 | $17K | |
| 90744 | <1% | 1,439 | $17K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,239 | $17K |
| 90680 | <1% | 1,251 | $17K | |
| 90734 | <1% | 669 | $14K | |
| 90698 | <1% | 865 | $14K | |
| 90700 | <1% | 1,164 | $14K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 827 | $14K |
| 80053 | Comprehensive metabolic panel | <1% | 1,055 | $11K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 419 | $10K |
| 90648 | <1% | 889 | $10K | |
| 84439 | <1% | 1,021 | $9K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 624 | $9K |
| 80050 | General health panel | <1% | 149 | $7K |
| 99381 | <1% | 78 | $7K | |
| 90619 | <1% | 406 | $7K | |
| 90716 | <1% | 291 | $6K | |
| 90715 | <1% | 496 | $6K | |
| 90710 | <1% | 404 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,021 | $6K |
| 99000 | <1% | 232 | $5K | |
| 90696 | <1% | 349 | $5K | |
| 90713 | <1% | 277 | $3K | |
| 87428 | <1% | 34 | $2K | |
| 90685 | <1% | 187 | $2K | |
| 90707 | <1% | 112 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 169 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 431 | $787.41 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 374 | $380.13 |
| 87209 | <1% | 25 | $376.50 | |
| 90621 | <1% | 13 | $369.78 | |
| 94760 | <1% | 290 | $312.60 | |
| 87427 | <1% | 25 | $312.50 | |
| 87045 | <1% | 25 | $307.50 | |
| 87449 | <1% | 13 | $203.84 | |
| 85652 | <1% | 78 | $201.74 | |
| 87177 | <1% | 25 | $180.00 | |
| 99051 | <1% | 70 | $160.00 | |
| 84436 | <1% | 13 | $87.36 | |
| 99072 | <1% | 141 | $63.75 | |
| 86140 | <1% | 13 | $61.10 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 416 | $51.96 |
| 87046 | <1% | 12 | $28.80 | |
| 1003F | <1% | 1,189 | $0.75 | |
| 1036F | 0% | 462 | $0.00 | |
| 1040F | 0% | 359 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.